Its also important to get adequate calcium and vitamin D while on GLP-1 medications
Eli Lilly holds multiple patents on orforglipron covering the compound itself, its synthesis, pharmaceutical formulations, and methods of use
The article points to people with type 2 diabetes, anyone taking other medications that affect glucose control, and people with a history of anxiety about missed doses
however, the risk of congenital anomalies following such exposure is not known
Trifecta doesn't offer a GLP-1-specific plan
The dose-response effect we observed where longer GLP-1 receptor agonist exposure was associated with higher risk strengthens the argument that this association may reflect a true biological effect rather than being due to confounding factors, said study co-author Andrew Mihalache, MD(C), of the Temerty Faculty of Medicine at the University of Toronto, Canada